ESC Premium Access

Superior actions of chronic peptide therapeutics with Cenderitide on cardiorenal function and remodeling compared to enalapril through reverse activation of gene pathways in experimental heart failure

Congress Session

About the speaker

Doctor Tomoko Ichiki

Mayo Clinic, Division of Cardiovascular Diseases and Internal Medicine, Rochester (United States of America)
0 follower

8 more presentations in this session

Are beta-blockers needed in patients after primary prevention implantable cardioverter-defibrillator? A multicenter population-based cohort study.

Speaker: Professor L. Fauchier (Tours, FR)

Thumbnail

Non-withdrawal of beta-blockers in acute decompensated chronic and de-novo heart failure is associated with lower in-hospital and 3-months mortality: Findings from the GULF-CARE

Speaker: Assistant Professor C. Abi Khalil (Doha, QA)

Thumbnail

Beta-blockers, ACE/ARB and MRA at discharge and outcome after hospitalization of heart failure in octogenarians with HFPEF and HFREF: a report from the BIO-HF registry

Speaker: Professor J. De Sutter (Gent, BE)

Thumbnail

Fingerprint of the renin-angiotensin-system during ARNI therapy in patients with systolic heart failure

Speaker: Doctor R. Wurm (Vienna, AT)

Thumbnail

Anti hypertrophic effects of LCZ696 in chronic cardiac pressure overload

Speaker: Mr E. Sjaastad Norden (Oslo, NO)

Thumbnail

Access the full session

Drug therapy of heart failure

Speakers: Doctor T. Ichiki, Professor L. Fauchier, Assistant Professor C. Abi Khalil, Professor J. De Sutter, Doctor R. Wurm...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk